In this study, we innovatively validated the specific mechanism of DDR1 in mediating MMDR in CRC and proposed an effective strategy to enhance the antitumor efficacy by actively modulating the tumor collagen matrix during chemotherapy. This evidence concerns the gene DDR1 and neoplasm.